TODAY'S NEWS



Merrion Pharmaceuticals Complete Euro 8 Million Funding Round

29th November, 2006
Merrion Pharmaceuticals Ltd, Dublin, announced the successful conclusion of an Euro 8 million funding round which was oversubscribed, and was managed on behalf of the company by Goodbody Stockbrokers.  Participation in this funding round was from previous investors in a Euro 6 million funding round conducted in April of this year.  The present offering closed on November 22. The principal investors included Dr. Tony Ryan and Mr Declan Ryan, Chairman of Merrion.

Merrion Pharmaceuticals was established in early 2004 after the life sciences private equity investor, Growcorp Group Ltd, acquired, in late 2003, a basket of technologies developed by Elan from 1994 through to a less stable 2002.  After completing a complicated due diligence Growcorp then recruited all the senior Merrion management.

Merrion Pharmaceuticals (www.merrionpharma.com) is now a privately held international speciality pharmaceutical company engaged in the development of improved oral dosage forms of drugs that are poorly absorbed including injectable drugs, certain existing oral drugs and large molecule drug candidates.  Merrion's primary focus is developing these new, improved oral dosage forms in order to improve physician and patient acceptance of these traditionally poorly absorbed drugs.


 
Copyright 2007 Growcorp Group. All Rights Reserved.
Office: Growcorp Group Limited, 3015 Lake Drive, Citywest Campus, Citywest, Dublin 24 | Telephone: +353 1 4661000 | Fax: +353 1 4661002
2009
Merrion’s new facility at Citywest officially opened by Minister Harney 29 October 2009. Growcorp the founding Shareholder of Merrion Pharmaceuticals the Irish Stock Exchange listed company today announced it was delighted with the opening by Merrion Pharmaceuticals of it new facility in Citywest.

Merrion Pharmaceuticals has purchased a new facility in order to expand its current research and development operations.
Merrion has acquired a 26,684 square foot pharmaceutical facility in Citywest, Co Dublin.

Merrion Lands Second $58M Deal. Irish drug development firm Merrion Pharmaceuticals has inked a second deal with Denmark-based medicine supplier Novo Nordisk that could be worth up to $58m (Eur44m) for the Dublin-headquartered company. Merrion was founded by Growcorp Group Ltd when it acquired extensive IP from Elan in early 2003 following over one years due diligence. Growcorp then developed a business plan and hired all senior management.

2008
Galway and Dublin. Wednesday, 3rd December, 2008: Growcorp Group, the Irish investment vehicle, will earn over Eur 7m following the acquisition this week of Irish theranoistic company Neutekbio by Danish biotechnology development company Merrion Pharmaceuticals has signed a multi-million euro deal with Novo Nordisk to develop oral diabetes products.

2008
DUBLIN, Ireland, Nov 5, 2008 an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award

2008
DUBLIN, Ireland, Nov 5, 2008 an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award

2008
Merrion Pharmaceuticals the TCD based Irish American company has confirmed that it has begun a joint feasibility study on oral drug delivery with Swiss based multinational Ferring Pharmaceuticals.

2007
Merrion Pharmaceuticals Plc was admitted to the IEX today and commenced
unconditional trading.........